Bank of Montreal
KIN

Bank of Montreal’s Kindred Biosciences, Inc. KIN Stock Holding History

Bank of Montreal’s Portfolio KIN Stock Details KIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-75,500
Closed -$300K – 5008
2020
Q2 		$300K Buy
+75,500
New +$337K ﹤0.01% 2524

Other funds holding KIN

PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

Bank of Montreal's KIN Position: Q2 2021 in Review

Bank of Montreal sold out of Kindred Biosciences, Inc. (KIN) in Q2 2021, closing a stake of 2,289 shares — an estimated $12K sold.

Bank of Montreal first reported a position in KIN in Q2 2014 and held it in 27 quarters. The position peaked at $199K in Q3 2014. 87 funds tracked by Wall St. Rank hold KIN as of Q2 2021.

  • Bank of Montreal reported no remaining Kindred Biosciences, Inc. position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 2,289 Kindred Biosciences, Inc. shares in Q2 2021, an estimated $12K.
  • Bank of Montreal first reported a position in Kindred Biosciences, Inc. in Q2 2014 and held it in 27 quarters.
  • Bank of Montreal's Kindred Biosciences, Inc. position peaked at $199K in Q3 2014.
  • 87 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.